Verified earnings results

60 Degrees Pharmaceuticals Q3 2026 Earnings Results

Direct answer

60 Degrees Pharmaceuticals reported Q3 2026 results on November 16, 2026.

Revenue was 233,240. EPS missed the estimate by 0.73%.
The result is verified against Verified earnings source.
Verified earnings source

Get free 60 Degrees Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Earnings date
November 16, 2026
Reported timing
During US market hours
EPS estimate
-0.7446
Reported EPS
-0.75
Revenue
233,240
EPS surprise
EPS missed the estimate by 0.73%.

Read the frequently asked questions.

When did 60 Degrees Pharmaceuticals report Q3 2026 earnings?

60 Degrees Pharmaceuticals reported on November 16, 2026. The reported timing was during us market hours.

What is the available EPS estimate for 60 Degrees Pharmaceuticals?

The verified record provides an EPS estimate of -0.7446.

Has 60 Degrees Pharmaceuticals reported the Q3 2026 result?

Revenue was 233,240. EPS missed the estimate by 0.73%.

Which source supports this 60 Degrees Pharmaceuticals earnings record?

The earnings record identifies Verified earnings source as its source. Missing values are not estimated.